Follicular mycosis fungoides: successful treatment with oral bexarotene.
Galina Shistik, Leigh Ann Scalf, Neil A. Fenske, L Frank Glass
Abstract
Galina Shistik, Leigh Ann Scalf, Neil A. Fenske, L Frank Glass
Abstract
Follicular mycosis fungoides, a subtype of cutaneous T-cell lymphoma, is often difficult to treat. We present a case of a female with follicular mycosis fungoides who showed an excellent response to low-dose (150 mg/m2) oral bexarotene (Targretin). To our knowledge, this is the first reported case of follicular mycosis fungoides demonstrating a response to bexarotene.
OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Follicular mycosis fungoides, a subtype of cutaneous T-cell lymphoma, is often difficult to treat. We present a case of a female with follicular mycosis fungoides who showed an excellent response to low-dose (150 mg/m2) oral bexarotene (Targretin). To our knowledge, this is the first reported case of follicular mycosis fungoides demonstrating a response to bexarotene.
Key concepts: Mycosis fungoides, Bexarotene, Medicine, Dermatology, Follicular phase, Peripheral T-cell lymphoma, Cutaneous T-cell lymphoma, Lymphoma